Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 8:26 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Venrock Healthcare Capital Partners III L.P. | 2,070,000 3.300% |
2,070,000 (New Position) |
Filing |